Trials / Unknown
UnknownNCT03742661
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Brain Sentinel · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, randomized, prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure monitoring and alerting system for Veterans with a history of motor seizures (epileptic, non-epileptic or unknown) with upper extremity motor involvement, presenting with questionable spell characterization, taking place in the home setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SPEAC System | Surface Electromyography (sEMG) based seizure monitoring and alerting system |
Timeline
- Start date
- 2018-11-02
- Primary completion
- 2021-01-01
- Completion
- 2026-01-01
- First posted
- 2018-11-15
- Last updated
- 2019-07-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03742661. Inclusion in this directory is not an endorsement.